title: Lysine-scanning mutagenesis reveals an amendable face of the cyclotide kalata B1 for the optimization of nematocidal activity.
abstract: Cyclotides are a family of macrocyclic peptides that combine the unique features of a head-to-tail cyclic backbone and a cystine knot motif, the combination of which imparts them with extraordinary stability. The prototypic cyclotide kalata B1 is toxic against two economically important gastrointestinal nematode parasites of sheep, Haemonchus contortus and Trichostrongylus colubriformis. A lysine scan was conducted to examine the effect of the incorporation of positive charges into the kalata B1 cyclotide framework. Each of the non-cysteine residues in this 29-amino acid peptide was successively substituted with lysine, and the nematocidal and hemolytic activities of the suite of mutants were determined. Substitution of 11 residues within kalata B1 decreased the nematocidal activity dramatically. On the other hand, six other residues that are clustered on the surface of kalata B1 were tolerant to Lys substitution, and indeed the introduction of positively charged residues into this region increased nematocidal activity. This activity was increased further in double and triple lysine mutants, with a maximal increase (relative to the native kalata B1) of 13-fold obtained with a triple lysine mutant (mutated at positions Thr-20, Asn-29, and Gly-1). Hemolytic activity correlated with the nematocidal activity of all lysine mutants. Our data clearly highlight the residues crucial for nematocidal and hemolytic activity in cyclotides, and demonstrate that the nematocidal activity of cyclotides can be increased by incorporation of basic amino acids.
authors.affiliation: Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia.
authors.forename: Yen-Hua
authors.initials: YH
authors.lastname: Huang
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Colgrave
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Clark
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Kotze
authors.forename: David J
authors.initials: DJ
authors.lastname: Craik
mesh_terms: D000818:Animals; D000969:Antinematodal Agents / Q000494:pharmacology*; D047169:Cyclotides / Q000737:chemistry / Q000235:genetics* / Q000494:pharmacology*; D047168:Cystine Knot Motifs; D004912:Erythrocytes / Q000187:drug effects; D041981:Gastrointestinal Tract / Q000187:drug effects* / Q000469:parasitology; D006188:Haemonchiasis / Q000188:drug therapy / Q000469:parasitology; D006189:Haemonchus / Q000187:drug effects* / Q000472:pathogenicity; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007814:Larva / Q000187:drug effects / Q000254:growth & development; D008239:Lysine / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D016297:Mutagenesis, Site-Directed; D012756:Sheep / Q000469:parasitology; D014253:Trichostrongylosis / Q000188:drug therapy / Q000469:parasitology; D014254:Trichostrongylus / Q000187:drug effects* / Q000472:pathogenicity
chemical_list: D000969:Antinematodal Agents; D047169:Cyclotides; C091930:kalata B1; D008239:Lysine